Company / Working Capital
Amphstar Pharmaceuticals, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$477.9M
FY2025
5-year range
$214.3M / $477.9M
FY2021-FY2025
Trend
+32.6%
vs FY2024
Sector context
#97 of 213
Health Care
What the data says
At $478M, Amphstar Pharmaceuticals, Inc.'s working capital ranks #97 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $114M in FY2018 to $478M in FY2025.
Based on SEC 10-K filings.
$478M in FY2025 with a 5-year CAGR of +23.3%.
Improved from $264M to $478M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +23.3%
- 10-Year CAGR
- -
Sector benchmark
#97 of 213 in Health CareTop 46% of 213This company $477.9M Sector average $934.6M
▼
-48.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.3%, indicating consistent growth.
- In FY2025, working capital increased 32.6% year-over-year.
- Ranks #97 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $477.9M | +32.6% |
| FY2024 | $360.3M | +36.4% |
| FY2023 | $264.2M | -6.8% |
| FY2022 | $283.5M | +32.3% |
| FY2021 | $214.3M | +28.0% |
| FY2020 | $167.5M | +1.4% |
| FY2019 | $165.2M | +45.6% |
| FY2018 | $113.5M | -5.9% |
| FY2017 | $120.6M | -2.3% |
| FY2016 | $123.5M | +6.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026